No Data
No Data
RBC Capital Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $116
Congressmember Tina Smith's New Portfolio Holdings
Investors More Bullish on Boston Scientific (NYSE:BSX) This Week as Stock Grows 5.6%, Despite Earnings Trending Downwards Over Past Five Years
Analysts Offer Insights on Healthcare Companies: 89bio (ETNB), Gain Therapeutics (GANX) and Boston Scientific (BSX)
Express News | FOMC Projects Lower GDP and Uncertainty, No Rate Change
Fed Dot Plot in Full View as Market Holds on a Higher Note: Live Stock News